Awareness and preparedness in smoking cessation among smoker patients scheduled for elective surgery in HUSM by Sulaiman, Al Jadidi
 AWARENESS AND PREPAREDNESS IN SMOKING 
CESSATION AMONG SMOKER PATIENTS SCHEDULED 
FOR ELECTIVE SURGERY IN HUSM 
 
 
 
BY 
DR AL JADIDI BIN SULAIMAN 
 
 
 
Dissertation Submitted In Partial Fulfillment of the Requirement for the Degree 
of Master of Medicine 
(ANAESTHESIOLOGY & INTENSIVE CARE) 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2016    
ii 
 
ACKNOWLEDGEMENT 
 
 
In the name of Allah SWT, the Most Gracious, the Most Merciful 
I would like to give my sincere gratitude and appreciation to Dr Laila Ab Mukmin for 
inspiring me, her valuable advices and guidance in completing my study with her full 
support. 
A special thanks to Professor Dr Shamsul Kamalrujan Hassan, Head Department of 
Anesthesiology, HUSM and his team of lecturers for their continuous support during 
completion of this study. 
A full of thanks to all patients, ward and operation theatre staffs for their full cooperation 
during the survey, and I hope this study will benefit all of you in the future… 
I would finally like to dedicate this dissertation to my family for their patience, support 
and endless love….. 
  
iii 
 
TABLE OF CONTENT 
Acknowledgement……………………………………………………………. ii 
List of Tables…………………………………………………………………. iv 
List of Figures………………………………………………………………… vii 
List of Symbols and Abbreviation……………………………………………. viii 
Abstrak………………………………………………………………………... ix 
Abstract……………………………………………………………………….. xi 
CHAPTER 1 
INTRODUCTION...……………………………………………………….. …. 1 
1.1 Background of the study…………….………………………. 1 
1.2 Statement of problem………………..………………………. 2 
1.3 Justification of the study…………………………………….. 3 
 
CHAPTER 2 
2.1 LITERATURE REVIEW……………………………………………… 4 
2.1.1 Smoking and surgical outcome……………………………… 4 
2.1.2 Pathophysiology of effect of smoking...……………………… 7 
2.1.3 Effect of preoperative intervention on postoperative outcome 8 
2.1.4 Long-term effect of preoperative interventions…………..…. 9 
2.1.5 Effects of cigarettes smoking on anaesthesia ………………. 10  
2.1.6 Predictors of smoking cessation........................................... …. 15 
2.1.7 When to stop smoking? ……………..……………………… 19 
2.1.8 Helping surgical patients quit smoking …………………….… 21 
2.1.9 How can anaesthesiologist help smokers quit? …………… … 25 
iv 
 
2.1.10 Intervention strategies…………………………...................  28 
2.1.11 Public awareness about anaesthesia and anaesthesiologist  31 
2.2 OBJECTIVES 
 2.2.1 General Objective………………………………………….  33 
 2.2.2 Specific Objectives………………………………………...  33 
2.3 RESEARCH HYPOTHESIS………………………………………  33 
 
CHAPTER 3 
METHODOLOGY……………………………………………….………..  34 
3.1 Study Design……………………………………………………….  34 
3.2 Population and Sampling…………………………………………..  34 
 3.2.1 Population reference……………………………………….  34 
 3.2.2 Source of population……………………………………….  34 
 3.2.3 Sampling frame ……………………………………………  34 
  3.2.3.1 Inclusion criteria…………………………………...  35 
  3.2.3.2 Exclusion criteria…………………………………..  35 
3.3 Sample size determination…………………………………………  35 
3.4 Sampling method……..……………………………………………  36 
3.5 Flow chart of study protocol………………………………………  36 
3.6 Data collection……………………………………………………..  37 
3.7 Study instrument……….…………………………………………..  37 
3.8 Statistical analysis …………………………………………………  38 
 
 
 
v 
 
CHAPTER 4 
RESULTS………………………………………………………………….. 39 
4.1 Patient characteristic……………………………………………….  39 
4.2 Objective 1 result (factor toward smoking cessation)……………..  49 
4.3 Objective 2 result (association between factors)...…………………  56 
 
CHAPTER 5 
5.1 DISCUSSION…………………………………………………….  59 
 5.1.1 Overview…………..………………………………………  59 
 5.1.2 Outcome…………….……………………………………..  61 
 5.1.3 Demographic profile………………………………………  62 
 5.1.4 Smoking status…………………………………………….  63 
 5.1.5 Role of cessation assistance……………………………….  64 
 5.1.6 Knowledge and awareness…………………………………  64 
5.2 Limitation of the study..……………………………………………  66 
5.3 Clinical implication of the study………………. …………………  67 
 
CHAPTER 6 
Summary and conclusion……………………………………………..……  68 
 
CHAPTER 7 
Recommendation for future study…………………………………………  70 
References…………………………………………………...…………….  71 
Apendices………………………………………...………………………..  76 
 
vi 
 
LIST OF TABLES 
 
TABLES               PAGE 
Table 2.1: Intraoperative and immediate postoperative complications  6 
Table 2.2: Some of the constituents of cigarette smoke     10 
Table 2.3: Summary of general information and tobacco control    17                             
                efforts in Malaysia and Thailand 
Table 4.1: Demographic, smoking-related characteristic of smoker    41 
      patients scheduled for elective surgery.   
Table 4.2: The descriptive analysis of social demographic based on   49 
      time of last smoke        
Table 4.3: The descriptive analysis of smoking status based on     50 
        time of last smoke        
Table 4.4: The descriptive analysis of role of cessation assistance,    51 
      knowledge and previous anesthetic experience based on 
      time of last smoke.  
Table 4.5: The descriptive analysis of knowledge & awareness based on   52  
      time of last smoke        
Table 4.6: The descriptive analysis of time of smoking cessation    55 
Table 4.7: Associated factors for time of last smoke by Simple Logistic     56   
     Regression model         
Table 4.8: Associated risk factors for time of last smoke by Multiple   57 
     Logistic Regression model        
 
 
vii 
 
LIST OF FIGURES 
 
FIGURES                 PAGE 
Figure 2.1: Methods of proven efficacy to help patients quit smoking  24 
Figure 2.2: An example of brief patient education material that can   30 
        be used by anesthesiologist in the perioperative period     
Figure 4.1: Distribution of smoker patients’ age scheduled for surgery  41 
Figure 4.2: Frequency of smoking cessation according to age group  42 
Figure 4.3: Frequency of smoking cessation according to employment  43 
Figure 4.4: Time of smoking cessation according to level of education  44 
Figure 4.5: Time of smoking cessation according to year of smoking  45 
Figure 4.6: Frequency time of smoking cessation according intention  46 
       to quit  
Figure 4.7: Effect of advice on time of smoking cessation    47 
Figure 4.8: Distribution of person who gives advice to stop smoking   48 
       to respondents        
Figure 5.1: Percentage of smokers who believe that smoking causes   65 
      the following health conditions or outcomes     
 
 
 
 
 
  
viii 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
CI  Confidence Interval 
CO  Carbon monoxide 
COHb  Carboxyhaemoglobin 
GOT  General Operation Theatre 
HUSM  Hospital Universiti Sains Malaysia 
NRT  Nicotine replacement therapy 
NSAIDS Nonsteroidal Anti Inflammatory Drug 
OR   Odds ratio 
RCT  Randomised Control Trial 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
ABSTRAK 
 
Tahap kesedaran dan kebersediaan untuk berhenti merokok dikalangan pesakit 
yang dijadualkan untuk menjalani pembedahan secara elektif di Hospital Universiti 
Sains Malaysia 
 
Pengenalan: Merokok adalah faktor penyebab yang boleh diubah untuk pelbagai 
penyakit dan kematian awal. Merokok dalam jangkamasa pembedahan adalah 
berhubungkait dengan pelbagai komplikasi dan morbiditi sehingga boleh menambahkan 
beban ekonomi. Pembedahan secara elektif memberi peluang yang baik untuk doktor 
bedah dan bius untuk membantu perokok berhenti merokok. Kajian ini bertujuan untuk 
mengenalpasti faktor untuk berhenti merokok dikalangan perokok sebelum menjalani 
pembedahan yang dijadualkan; dan menentukan kesan latar belakang, status merokok dan 
pengetahuan mengenai risiko kesihatan berkaitan merokok terhadap sikap tersebut.   
Metodologi: 106 pesakit yang merokok yang dijadualkan untuk pembedahan 
secara elektif di Hospital Universiti Sains Malaysia terlibat dalam kajian; dari April 
hingga September 2015. Kajian ini melaporkan keputusan  hasil kajian secara ‘cross-
sectional’ terhadap pesakit-pesakit terlibat dengan melengkapkan soalan kajiselidik 
sebelum atau sehari selepas pembedahan. Soalan kajiselidik ini merangkumi tiga 
bahagian iaitu latar belakang subjek, status merokok dan pengetahuan mengenai risiko 
yang berkaitan dengan merokok. 
x 
 
Results:  Purata umur bagi subjek adalah 37 (SD, 17.3). 60.4% (n=64) pesakit 
berhenti merokok lebih dari 24 jam sebelum masa pembedahan, dan 39.6% (n=42) lagi 
berhenti kurang dari 24 jam sebelum pembedahan. Mempunyai niat untuk berhenti 
merokok didapati merupakan faktor terpenting untuk pesakit berhenti merokok didalam 
kajian ini. Perokok yang tidak mempunyai niat untuk berhenti merokok mempunyai 4.32 
odd yang lebih tinggi untuk berhenti merokok kurang dari 24 jam sebelum pembedahan 
berbanding dengan subjek yang mampunyai niat untuk berhenti merokok (95% CI: 1.85, 
10.10, p-value<0.001). 
Kesimpulan: Melihat kepada banyak kesan kesihatan yang baik jika berhenti 
merokok sebelum pembedahan, doktor bedah dan bius sepatutnya memainkan peranan 
mereka, sekurang-kurangnya memberi nasihat untuk berhenti merokok, atau yang sebaik-
baiknya melibatkan program rawatan berhenti merokok. Pengenalan kepada ‘nicotine 
replacement therapy (NRT)’ akan meningkatkan peluang untuk terus berhenti terhadap 
para perokok.  
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ABSTRACT 
 
Awareness and preparedness in smoking cessation among smoker patient scheduled 
for elective surgery in Hospital Universiti Sains Malaysia 
 
Background: Smoking is the single most cause of preventable disease and 
premature death. Perioperative smoking is linked to various complications and morbidity 
and to a significant economic burden. Elective surgery offers a powerful opportunity for 
surgeon and anesthetist to help smokers quit. This study set out to identify factor or 
predictor toward smoking cessation among smoker patients prior to scheduled surgery; 
and to determine how sociodemographic background, smoking status and knowledge on 
the health risks of smoking contribute toward development of such attitude. 
Methodology: 106 smoker patients who scheduled for elective surgery in 
Hospital Universiti Sains Malaysia were enrolled from April till September 2015. This 
paper reports the results of a cross-sectional study on these patients by filling 
predetermined questionnaire before anesthesia and surgery or on the first operative day. 
The survey included three sections exploring demographical profile of respondent, 
smoking status and knowledge regarding smoking-related risks. 
 Results:  Mean age of respondent was 37 (SD, 17.3). 60.4% (n=64) patients 
stopped smoking more than 24 hour prior to surgery while the other 39.6% (n=42) had 
cessation less than 24 hour preoperatively. Intention to quit turned out to be the most 
xii 
 
significant predictor for early smoking cessation in this study. Smoker patients who did 
not have intention to stop smoking had 4.32 higher odds of cessation less than 24 hour 
compare to those who had intention to stop smoking (95% CI: 1.85, 10.10, p-
value<0.001). 
Conclusion: Considering many beneficial effects of preoperative smoking 
cessation, both surgeon and anesthetist should play their role to achieve this; to the least 
of brief smoking cessation advice, and to the extent of any form of smoking cessation 
interventions. Introduction of nicotine replacement therapy will double the chance of 
abstinence and cure among smokers.  
Keywords: Smoking cessation, Elective Surgery, Awareness, Preparedness 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 BACKGROUND OF THE STUDY 
 
Tobacco use is the most important preventable cause of disease and death in 
the world today. This is true in most countries in the world including Malaysia. An 
estimated 10,000 Malaysian deaths are attributed to smoking-related diseases 
annually. In 2006, diseases related to smoking account for at least 15% of 
hospitalized cases and approximately 35% of hospital deaths (KH., M.G, & N.M, 
2009). 
   
 Many physicians are not aware that there has been great progress in recent 
decades in the treatment of tobacco dependence, as summarized in the United States 
Public Health Service Guideline and Tobacco Use and Dependence. Main 
recommendation of this report is to „systemically identify all tobacco users who 
come in contact with the health care system, strongly urge them to stop, and aid them 
in doing so‟. (Fiore et al., 2008) 
   
 Cigarettes smoke contains over 4700 additional chemical compounds other 
than nicotine. It includes at least 43 carcinogens which generate broad 
pathophysiological effects. Failure to quit smoking before elective or emergency  
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surgery is ill judged which can lead to subsequent risk of intra and postoperative 
complications. The link between smoking and post-operative complication is well 
documented across surgical specialties. Not only is there an increased mortality risk, 
but also other complications including pulmonary, respiratory, wound infections, 
delayed wound healing and reduced bone fusion. 
  
 With regards to anaesthesia, main complications are related to cardiovascular 
and respiratory systems. There will be an increase in blood pressure, heart rate and 
systemic vascular resistance. Respiratory problems include impaired in oxygen 
uptake, transport and delivery; both during and after anesthesia. (Rodrigo, 2000). 
Smoking has been associated with increased length of time in intensive care, 
prolonged recovery from surgery and prolonged stay in the ward. (David O Warner, 
Michael G Sarr, Kenneth P Offord, & Lowell C Dale, 2004). 
 
1.2 STATEMENT OF THE PROBLEM 
 
 Despite all the complications and risks, the incidence of smoking  is about 
30% for general surgical populations undergoing elective procedures and 14-38% for 
emergency procedures in western countries (Tonnesen, Nielsen, Lauritzen, & 
Moller, 2009), with advice on smoking cessation varying from surgeon to surgeon. 
Only 58% of surgeons and 30% of anesthetist routinely advice patients to stop 
smoking before undergoing surgical procedure (D. O. Warner, M. G. Sarr, K. P. 
Offord, & L. C. Dale, 2004). 
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Lim et al, in 2009 found that locally in Malaysia, knowledge and attitude 
among Malaysian smokers differ according to smoking status, education level and 
knowledge of health effect of tobacco products. On the other hand, only about 20-
55% of patients are actually aware regarding role of anaesthesia and the risk related 
to it (Baaj & Takrouni, 2006; M.G., S., & S.K.Y., 1998; Naithani & Purohit, 2007). 
There is no study previously specifically look at predictors for smoking cessation 
among patient going for anaesthesia and surgery. 
 
1.3 JUSTIFICATION OF THE STUDY 
  
 To the best of author‟s knowledge, no report has been found so far 
highlighting our local data pertaining our patients‟ level of awareness and 
preparedness before undergo anaesthesia and surgical procedure, in particular among 
the smokers. This study was designed to determine association factors or predictors 
for smoking cessation among smokers who are scheduled for elective surgery. At the 
same time, the level of understanding regarding importance of abstinence prior 
surgery can be obtained.  
 
 Since Hospital Universiti Sains Malaysia is a tertiary hospital which receives 
various cases and referrals not only form Kelantan but also form other neighbouring 
state, local data form this hospital might reflect general population for instance.  
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CHAPTER 2 
 
2.1 LITERATURE REVIEW 
 
 In the past 20 years, the Malaysian government has recognized the 
importance of reducing smoking rates. Indeed the Malaysian National Health and 
Morbidity Survey found that smoking prevalence among adults 18 years old and 
older has decreased from 24.8% in 1996 to 21.5% in 2006. However, smoking 
prevalence is still extremely high, particularly among men. In Malaysia, almost half 
(46.4%) of all men smoke, whereas few (1.6%) women do (Omar, Awang, & Samin, 
2012). Smoking prevalence among young people indicates continued high rates of 
future death and disease due to smoking. 
 
 
  
2.1.1 Smoking and surgical outcome 
 
 Quitting smoking in community setting is influenced by physician quit 
advice and knowledge of smoking hazards, but there are few data on whether this 
applies in perioperative setting.  Smoking and hazardous alcohol drinking are the 
most frequent lifestyle risk factors that can influence the outcome after surgery. The 
incidence of smoking is about 30% for general surgical populations undergoing 
elective procedures and 14–38% for emergency procedures in the western world 
(Tonnesen et al., 2009). The incidence is often higher than the general population. 
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Numerous studies have shown that smoking is associated with postoperative 
morbidity. Status as a current cigarette smoking is an independent risk factor for 
many postoperative complications (Moores, 2000).  Smoking affects human 
physiology in different ways even in the absence of end-organ disease. The system 
most commonly  affected by smoking are pulmonary function, cardiovascular 
function, the immune response , and tissue healing (M. Warner, Divertie, & Tinker, 
1984).  Smoking as well can alter the hepatic metabolism of commonly used drugs. 
 
  The most common perioperative complications related to smoking are 
impaired wound and tissue healing and wound infection, and cardiopulmonary 
complications (D. O. Warner, 2006). The relative risk of complications after surgery 
for smokers compared to non-smoker has been reported  to increase from 1.4-fold to 
4.3 fold (Hadi & Azrina, 2009). 
 
 Factors associated with an increased likelihood of developing pulmonary 
complications include: (Bluman & Mosca, 1998) 
i. Pre-existing chronic lung disease 
ii. Abnormal results of pulmonary function test 
iii. Age > 60 years 
iv. Upper abdominal or thorasic surgery 
v. Smoking 
vi. Obesity 
vii. Total anaesthesia time > 3 hour 
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Table 2.2: Intraoperative and Immediate Postoperative Complications (Lee, Landry, 
Jones, Buhrmann, & Morley-Forster, 2013)    
 
 
Cardiovascular complications 
 
• Myocardial ischaemia / infarction, stroke, pulmonary embolism 
• Bradycadia, tachycardia, arrhythmia requiring physician assessment and/ or 
treatment 
• Hypotension or hypertension 
 
Respiratory complications 
 
• Unexpected oxygen desaturation requiring physician assessment / treatment 
• Excessive secretions or coughing 
• Postoperative need of ventilator support 
• Bronchospasm requiring therapy 
• Cancellation of surgery due to poor respiratory status 
 
Other 
 
• Inadequate pain control 
• Nausea or vomiting 
• Excessive bleeding requiring intraoperative treatment, unexpected 
transfusion, or postoperative dressing changes 
• Agitation, delirium or confusion 
• Need for internal medicine (general or subspecialty) or critical care 
consultation 
• Death from any cause 
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2.1.2 Pathophysiology of effect of smoking  
 
 Pathological changes in smokers undergoing surgery have shown that 
smokers have multiple organ changes with potential effects on their surgical course. 
Increased levels of carbon monoxide (CO)  in blood and up to 15% of the 
haemoglobin oxygen binding sites can be occupied by CO, resulting in significant 
reduction of the amount of oxygen available for cellular processes (Hlastala, 
McKenna, Franada, & Detter, 1976).  
 
 In addition, high p-nicotine levels mimic the sympathetic reflexes resulting in 
increased heart rate and arterial pressure and reduced peripheral blood flow. 
Consequently, oxygen consumption increased and reduced oxygen delivery. This 
may produce a relative hypoxia particularly in the heart and the peripheral tissue 
including surgical wounds. 
 
 Smoking also impairs immune function leading to an increased risk of 
infection (Hersey, Prendergast, & Edwards, 1983). Immune system appears to 
recover after 4-6 weeks of abstinence from smoking. Wound healing process is 
affected by smoking due to interference with the production of collagen. 
 
 Even for young, asymptomatic smokers have reduced pulmonary capacity, 
increased mucus production, and reduced ciliary function (Hans, Marechal, & 
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Bonhomme, 2008). This may lead to perioperative pulmonary complications. These 
pulmonary changes will improve over 6-8 weeks of abstinence from smoking 
(Hilding, 1956).  
 
2.1.3 Effect of preoperative intervention on postoperative outcome 
   
 Up to 2009, six randomised studies of preoperative smoking cessation 
intervention have been published, with quit rates were found to be 40-89% 
(Lindström et al., 2008). There was one published study of 102 patients undergoing 
general surgery showed that a 3-4 weeks smoking cessation programme reduced the 
incidence of postoperative complications from 41% to 21% , P=0.03. The evidence 
level is 1b and the recommendation strength A for preoperative smoking cessation 
programmes of 3-4 and of 6-8 weeks duration. A review concluded that 
implementation of smoking cessation programmes 3-8 weeks preoperatively are 
cost-effective in reducing postoperative complications, that they are a matter of 
quality management.(Tonnesen et al., 2009) 
 
 Several trials showed that even short term preoperative smoking cessation 
interventions, particularly those started > 4 weeks preoperatively, can reduce 
postoperative complications by up to 20 to 34%. (Lindström et al., 2008; A. Moller 
& Villebro, 2005) 
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 The beneficial effects of smoking intervention have been shown to be most 
important for wound healing and pulmonary complications (Møller, Villebro, 
Pedersen, & Tønnesen, 2002). Two clinical studies have reported that cessation of 
smoking more than 3 weeks before operation reduced the occurrence of wound 
healing complications in relation to head and neck and breast reduction surgery. 
(Kuri, Nakagawa, Tanaka, Hasuo, & Kishi, 2005). However no clinical studies have 
determined the optimal duration of preoperative smoking cessation intervention. 
 
2.1.4 Long-term effect of preoperative interventions    
 
 In 2008, Villebro et al follow-up on the preoperative smoking cessation 
programme. The intervention group had significantly higher quit rate 1 year after the 
programme, 22% vs 3%, P<0.01. One year smoking cessation is related to gender 
(men), low nicotine dependency, non-smoking spouse, and preoperative smoking 
intervention. All patients gave the same reasons for smoking cessation; improved 
health and saving money.  
 
 In one systematic review, the result indicated that preoperative smoking 
cessation interventions can increase smoking cessation rates before operation and for 
up to as long as 12 months after surgery. Interventions include counseling initiated at 
least 4 weeks before operation and nicotine replacement therapy. (Thomsen, 
Tønnesen, & Møller, 2009) 
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2.1.5 Effects of cigarettes smoking on anaesthesia 
 
 Cigarette smoke contains over 4700 additional chemical compounds other 
than nicotine; some of which are pharmacologically active, some antigenic, some 
cytotoxic, some mutagenic and some others carcinogenic (Holbrook, 1977). It 
consists of gaseous phase and particulate phase. (Table 2.3) 
 
Table 2.2: Some of the constituents of cigarette smoke (Sweeney & Grayling, 
2009) 
Gaseous portion Particulate portion  
Aldehydes 
Ammonia 
Arsenic  
Benzene 
Carbon monoxide 
Hydrogen cyanide 
Nitric oxide 
Nitrogen dioxide 
Toluene 
Toluidine 
Acids 
Alcohols 
Aldehydes 
Amides 
Brown pigments 
Cadmium 
Carbohydrates 
Esters 
Imidazoles 
imides 
 
Insecticides 
Lactames 
Lactone 
Nicotine 
Nitrosamine 
Polyphenols 
Pyridines 
Vinyl chloride 
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1. Effects on cardiovascular system 
i. Increase in systolic and diastolic blood pressure, heart rate and 
peripheral vascular resistance 
ii. Increase myocardial oxygen consumption 
iii. Polycythemia due to chronic hypoxia 
iv. 70% greater risk for coronary artery disease due to increased blood 
viscosity 
v. Expired CO concentration, an indicator of recent smoking, is 
correlated with the frequency of ST depression during general 
anaesthesia (Woehlck, Connolly, Cinquegrani, Dunning III, & 
Hoffmann, 1999). 
 
2. Effect on the respiratory system 
i. Mucus becomes hyperviscous, cilia becomes inactive; thus resulting 
impaired tracheobronchial clearance. 
ii. Increase laryngeal and bronchial reactivity 
iii. 25% of smokers suffer from chronic bronchitis (Schwilk, Bothner, 
SCHRAAC, & Georgieff, 1997), incidence of chronic obstructive 
airway disease is also higher than in nonsmokers. 
 
Following smoking cessation: 
a) Ciliary activity starts to recover within 4-6 days (Egan & Wong, 
1992) 
b) Sputum volume takes 2-6 weeks to return to normal 
c) Improvement in tracheobronchial clearance after 3 months 
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d) 5-10 days for laryngeal and bronchial reactivity to settle 
Available studies estimating that at least 2 months of abstinence is 
required before postoperative pulmonary risk diminishes. (Moores, 2000; 
Woehlck et al., 1999) 
 
3. Effect on perioperative events 
i. Schwilk et al found that incidence of respiratory events such as 
reintubation, laryngospasm, bronchospasm, aspiration, 
hypoventilation, hypoxemia is 5.5% in smokers, compared with 3.3% 
in nonsmokers. 
ii. Current smokers are 2 to 6 times more likely than noncurrent smokers 
to develop a postoperative pulmonary complication.(Bluman & 
Mosca, 1998) 
iii. Relative risk for perioperative events in all smokers is 1.8, 2.3 in 
young smokers, and in obese smokers it was 6.3 times the normal. 
iv. Inaccuracy of pulse oximeters monitoring due to overestimation of 
the oxygen saturation resulting from higher level of COHb in the 
blood (Alexander, Teller, & Gross, 1989) . 
 
4. Effect on postoperative morbidity 
• Hypoxia occurs more following general anesthesia; compared with 
spinal anesthesia (J. Moller, Wittrup, & Johansen, 1990) 
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5. Effects of smoking cessation prior to surgery on postoperative morbidity 
i. Warner et al reported pulmonary complications such as purulent 
sputum, atelectasis, and pleural effusion in those that had stopped 
smoking for 8 weeks or more prior to surgery to be only 14.5%, 
compared with 57.9% in those who stopped smoking less than 8 
weeks before surgery, a four times higher incidence in those who 
stopped less than 8 weeks from surgery. 
ii. Warner et al found that, if patients stopped smoking for 6 months or 
more prior to surgery, the incidence was the same as that in non-
smokers.  
 
 
6. Effect on postoperative nausea and vomiting (PONV) 
• Incidence of PONV is less in smokers compared with both 
nonsmoking males and in females. It is suggested that this may be due 
to antiemetic effect in the constituents of smoke (Chimbira & 
Sweeney, 2000). 
 
 
7. Effect on the immune system 
i. Smoking impairs the immune response. The result is increased risk of 
infection and neoplasia.(Glasson, Sawyer, Lindley, & Ginsberg, 
2002) 
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ii. Healing of surgical wounds may be impaired, especially after 
procedures such as face lifts that require wide undermining of skin 
flaps.(Silverstein, 1992) 
 
8. Effect on drug metabolism 
• Cigarette smoking induces liver microsomal enzymes, increasing the 
metabolism of some drugs. There is no effect on thiopentone, 
lignocaine or corticosteroids (Miller, 1989). 
 
9. Effect on pain and analgesic drugs 
i. Chronic smokers exhibit a decreased tolerance to pain (Miller, 1989). 
Thus, independent of the action on the analgesic drugs, they require 
more analgesics for pain. 
ii. In one study, author found that both smoking and alcohol 
consumption significantly influenced the requirement for pethidine 
and morphine (Glasson et al., 2002). 
iii. There is no consistent evidence to support altered pharmacokinetics 
of paracetamol and Nonsteroidal Anti Inflammatory Drugs (NSAIDS) 
among smokers. 
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2.1.6 Predictors of smoking cessation 
 
 The relationship between socioeconomic status and smoking is well 
established, with lower socioeconomic groups having a markedly higher prevalence 
of smoking in developed and many developing countries. Apart from level of 
education and occupation, smoking has also been associated with other direct 
indicators of deprivation such as financial stress (Huisman, Kunst, & Mackenbach, 
2005; Sorensen, Gupta, & Pednekar, 2005).   Siahpush et al. in 2007 reported that in 
Australia, smoking households headed by people with lower education and 
occupation spent more money on tobacco. He also showed that households with 
lower income were more likely to spend a higher percentage of their total household 
income on tobacco. 
 
 As a healthcare provider, it is important to understand factors that are 
associated with quitting behaviours in specific cultural and socioeconomic settings in 
order to provide people with appropriate support in their efforts to quit. Most related 
research are actually comes from Western developed countries. There is evidence 
that predictors of making quit attempts differ from those predict outcome among 
those who try. (Hyland et al., 2004) 
 
 Sociodemographics predictors of making attempt include being young 
(Hyland et al., 2004), male gender (Nides et al., 1995), white race (Tucker, 
Ellickson, Orlando, & Klein, 2005), and well educated (Hatziandreu et al., 1990). On 
the other hand, smoking-related predictors of making attempts include level of 
nicotine dependence (Hyland et al., 2006), measures of intention / motivation 
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(Hyland et al., 2006), past quit attempts, self-efficacy (Woodruff, Conway, & 
Edwards, 2008) and concern for health effects caused by smoking. (Hyland et al., 
2006).  
 
 This knowledge from developed countries is not necessarily generalizable to 
developing countries, due to different socioeconomic conditions and cultural 
contexts as well as disparities in tobacco policies and social acceptability of 
smoking. Siahpush et al. in 2008 examined the association of socioeconomic 
position with cigarette consumption, intention to quit, and self-efficacy to quit 
among male smokers in Thailand and Malaysia using the ITC–Southeast Asia (SEA) 
survey. They found that in the Malaysian sample, higher level of education was not 
associated with intention to quit or self-efficacy to quit or cigarette consumption; in 
Thailand, higher level of education was associated strongly with not having self-
efficacy, and higher income was not found to be associated with an intention to quit 
in either country. As a matter of fact, smoking prevalence, particularly among men, 
is higher in Malaysia than in Thailand (Table 2.1).  These findings differs from 
studies in Western countries where higher level of education and socioeconomic 
status are predictive of making quit attempts and/or associated with staying quit. 
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Table 2.3: Summary of general information and tobacco control efforts in Malaysia 
and Thailand (Li et al., 2010) 
 
 Malaysia Thailand 
-Populations (millions) 26 64 
-Smoking prevalence 
   Male (%) 
   Female (%) 
 
45 
2.5 
 
37 
2 
-Number of fulltime equivalent employees in    
National Tobacco Control Agency 
3 18 
-Taxation (%) 39 79 
-availability of NRT Pharmacy prescription 
 
 
 
 
 Locally in this region, Li et al 2 years later in 2010 examined prospective 
predictors of smoking cessation among adult smokers in Thailand and Malaysia. 
This study used longitudinal data from the International Tobacco Control Southeast 
Asia Survey. In this study, the aim was to find out whether the determinants of 
quitting are similar to those found in Western countries. 
 
  4004 smokers were surveyed in Malaysia and Thailand in 2005. Of these, 
2426 smokers were followed up in 2006. The measures that had been taken were 
sociodemographics, dependence, and interest in quitting. Authors found that more 
Thai than Malaysian smokers reported having made quit attempts between the 2 
waves. However among those who tried the rate of staying quit were not 
considerably different between Malaysians and Thais. 
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 Multivariate analyses showed that smoking fewer cigarettes per day, higher 
level of self-efficacy and more immediate quitting intentions were predictive of both 
making a quit attempt and staying quit. Previous shorter quit attempts and higher 
health concerns about smoking were only predictive of making an attempt, whereas 
prior abstinence for 6 months or more and older age was associated with 
maintenance. In Malaysia, those retained the cessation were more likely to have 
lower education, be from dominant ethnic group (Malays), have stronger intention to 
quit, a previous quit history, higher self-efficacy, and a higher level of health 
concerns about smoking. 
 
 Various factors that influence smoking have been identified. They are social 
norms, social influence and social and economic status (KH. et al., 2009). Previous 
studies have identified knowledge on the hazards of smoking as a protective factor 
and positive attitude toward smoking as a risk factor for smoking especially among 
girls (Spear & Akers, 1987). Several studies revealed that smokers tend to downplay 
the adverse effect of smoking on health. This may be due to ignorance of the dangers 
of smoking or cognitive dissonance at work, wherein the smoker realises that 
smoking is harmful to health but to minimise psychological dissonance, downplays 
the risks through cognitive process so that it is compatible with his smoking habit 
(McMaster & Lee, 1991).  
 
Previous studies also revealed that those who smoke especially heavy 
smokers have positive attitudes towards smoking compared to former smokers and 
non-smokers. Besides smoking status, attitude towards smoking is also associated 
with socioeconomic background. People with higher education have more negative 
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attitudes towards smoking and those with higher income believe that cardiovascular 
diseases and cancer are strongly associated with smoking compared to those with 
low income (Manfredi, Lacey, Warnecke, & Buis, 1992).  
 
 
2.1.7 When to stop smoking? 
 
 Previous studies have demonstrated conflicting results with respects with 
respect to preoperative smoking cessation and postoperative risk. There have been 
concerns that stopping smoking within 8 weeks before surgery (recent quitters) may 
be detrimental to postoperative outcomes. This has generated considerable 
uncertainty in health care systems that consider smoking cessation advice in the 
hospital setting an important priority. This concern originated from a 1989 article 
that found postoperative pulmonary complications in 6 of 18 continuing smokers, 
compared with 12 of 21 ex-smokers who quit for less than 8 weeks prior to surgery 
(M. A. Warner et al., 1989). In this article, the author suggested that losing the 
cough-promoting effect of cigarettes before any improvement in sputum clearance 
might predispose to retentions of secretions and pulmonary complications. 
 
 Lawrence and Duncan in 1995 suggested that smoking cessation immediately 
before surgery did not appear to reduce the risk of pulmonary complications. 
Possible explanation for the unfavourable result was selection bias. Sicker patients at 
increased risk of postoperative pulmonary complications may have been more likely 
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to cut down on smoking prior to surgery. Another study by Leslie et al in 1998 also 
found that current smokers who reported reducing cigarette consumption prior to 
surgery were more likely to develop a complication compared with those who did 
not (adjusted OR= 6.7, 95% CI, 2.6 to 17.1).  
 
  However, later in meta-analyses, quitting smoking within 8 weeks before 
surgery was not associated with an increase or decrease in overall postoperative 
complications for all available studies (Myers, Hajek, Hinds, & McRobbie, 2011). 
The authors suggested that patients should be advised to stop smoking as early as 
possible, but there is no evidence to suggest that health professionals should not be 
advising smokers to quit at any time prior surgery. Lee et al in 2013 also did not 
detect any increase in intraoperative or immediate postoperative complications in the 
intervention group; who had been enrolled in 3 weeks prior to surgery. (Lee et al., 
2013). In a different study, Moller and Villebro conclude that the impact on 
complications may depend on how long before surgery the smoking behaviour is 
changed, whether smoking is reduced or stopped completely, and the type of 
surgery. 
 
 Surgeons on the other hand may find cancelling an elective operation because 
a smoker has not quit smoking, resulting in delayed treatment and loss of revenue. A 
patient who has had his operation cancelled by one surgeon can likely to find a 
different surgeon willing to perform the procedure. Further compounding this 
dilemma is a concern for smokers‟ rights to privacy, possible discrimination, and 
fears that physicians may be stigmatizing smokers; a negative message delivered by 
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a physician may result in a frightened patient unwilling to see that physician again. 
However, operating on active smokers results in higher health care costs and 
jeopardizes the patient-physician relationship by knowingly placing patients at 
higher risk for surgical complications. (Dhruv Kullar, Schoeder, & Maa, 2013) 
 
 
2.1.8 Helping surgical patient quit smoking 
 
 Smoking has been associated with increased length of time in intensive care, 
in recovery from surgery and on the ward (Theadom & Cropley, 2006). Despite this, 
a quarter of patients undergoing surgery continue to smoke up to, and after surgery; 
with advice on smoking cessation varying from surgeon to surgeon. Dhruv Kullar et 
al (2013) also added 25% to 30% of patients still smoke perioperatively. Warner et 
al revealed that only 58% of surgeons and 30% of anaesthetist routinely advise 
patients to stop smoking before undergoing surgical procedure. 
 
 A physician‟s advice to stop smoking provides important motivation for 
smokers to quit; however only half of current smokers report ever been asked about 
their smoking status or advised to quit by their physician, and even fewer have 
received specific advice on how to quit.(D. O. Warner, 2005)  
Scheduling of elective surgery represents an excellent opportunity for 
smokers to permanently quit, with great benefit for their long term health. Elective 
surgery may represent a „teachable moment‟, where smokers more likely to quit. 
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„Teachable moments‟ are health experiences that provide motivation to reduce risky 
behaviours and adopt positive behaviours.(Lawson & Flocke, 2009) 
 
 Although it is difficult for smokers to quit, there are now several 
interventions of proven benefit that can increase the chance of success (D. O. 
Warner, 2005). Moller and Villebro in 2005 reviewed the available literature on the 
effectiveness of interventions to help patients to stop smoking before surgery. Four 
RCT were reviewed and concluded that the interventions were effective in helping 
people to stop smoking preoperatively. The interventions that can be carried out 
include simple physician advice to quit, brief behavioural interventions that can be 
provided by physicians or other clinicians, and pharmacotherapy with drugs such as 
nicotine. 
 
 Preoperative period undeniably is an ideal time to help smokers to quit before 
being admitted to hospital. With many hospitals becoming smoke-free environments, 
some period of abstinence is mandatory, such that all smokers must at least 
temporarily address their tobacco dependence.  
 
 The efficacy of several interventions is supported by multiple randomised 
clinical trials (Figure 2.1). However, most of these trials have involved the general 
ambulatory population, and very few have specifically investigated surgical patients. 
More intensive interventions are even more effective. There is a dose-response 
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relationship between the total time spent in interventions and efficacy. It can be 
implemented by any provider with equal effectiveness. (D. O. Warner, 2005). 
 
  Pharmacotherapy in addition is an important element; with the use of this 
medications doubles the rate of abstinence (Hughes, Goldstein, Hurt, & Shiffman, 
1999). A randomised clinical trial in 2013 demonstrated that addition of nicotine 
replacement therapy to counselling, and vice versa, improved smoking cessation 
rates over monotherapy alone both in hospitalised patient and in the general 
population (Rigotti, Munafo, & Stead, 2007).  
 
 There is increasing evidence of the importance of adding nicotine 
replacement therapy (NRT) to counselling as NRT increases the rate of smoking 
cessation by 50-70%. The effectiveness of NRT appears to be largely independent of 
additional support provided to the smoker.(Silagy, Lancaster, Stead, Mant, & 
Fowler, 2004) 
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Proven Methods  
To Help Smokers Quit 
 
 
 
 
 Counselling       Pharmacotherapy 
       
 
 
 
 
 
*efficacy increases with the intensity of interventions and with the use of multiple 
counselling formats 
Figure 2.1: Methods of proven efficacy to help patients quit smoking (D. O. Warner, 
2005) 
 
 
  
• Physician advice to quit 
• Minimal intervention by a 
clinician (< 3 min in duration) 
• More intensive interventions 
by clinicians* 
-individual contact 
-group counseling 
-proactive telephone 
counseling  
• Nicotine replacement 
therapy 
-gum 
-patch 
-inhaler 
-nasal spray 
-lozenge 
• Buproprion SR 
• clonidine 
